Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan

Overview

Journal Clin Endosc

Date 2012 Aug 7

PMID 22866246

Citations 2

Authors

Byung Ik Jang

Affiliations

Soon will be listed here.

Citing Articles

Organ-specific accuracy of [F]FDG-PET/CT in identifying immune-related adverse events in patients with high-risk melanoma treated with adjuvant immune checkpoint inhibitor.

Gideonse B, Birkeland M, Vilstrup M, Grupe P, Naghavi-Behzad M, Ruhlmann C Jpn J Radiol. 2024; 42(7):753-764.

PMID: 38504000 PMC: 11217074. DOI: 10.1007/s11604-024-01554-y.

Lesion Location in Clinical Significance of Incidental Colorectal FDG Uptake.

Lee J, Hartnett G, Kumar A Clin Endosc. 2012; 45(4):451-2.

PMID: 23251900 PMC: 3521954. DOI: 10.5946/ce.2012.45.4.451.

References

Patrikeos A, Mackay J, Hicks R . Detection of synchronous adenocarcinomas and multiple dysplastic polyps with F-18 FDG positron emission tomography in a case of nonfamilial polyposis. Clin Nucl Med. 2003; 28(6):487-8. DOI: 10.1097/01.RLU.0000067510.43457.52. View

Cook G, Fogelman I, Maisey M . Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996; 26(4):308-14. DOI: 10.1016/s0001-2998(96)80006-7. View

Roh S, Jung S, Kim S, Kim H, Lee M, Tae C . The Clinical Meaning of Benign Colon Uptake in (18)F-FDG PET: Comparison with Colonoscopic Findings. Clin Endosc. 2012; 45(2):145-50. PMC: 3401618. DOI: 10.5946/ce.2012.45.2.145. View

Strauss L, Klippel S, Pan L, Schonleben K, Haberkorn U, Dimitrakopoulou-Strauss A . Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?. Eur J Nucl Med Mol Imaging. 2007; 34(6):868-77. DOI: 10.1007/s00259-006-0319-8. View

Drenth J, Nagengast F, Oyen W . Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med. 2001; 28(12):1766-9. DOI: 10.1007/s002590100645. View

Weston B, Iyer R, Qiao W, Lee J, Bresalier R, Ross W . Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer. 2010; 116(6):1454-61. DOI: 10.1002/cncr.24885. View

Rigo P, Paulus P, Kaschten B, Hustinx R, Bury T, Jerusalem G . Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med. 1996; 23(12):1641-74. DOI: 10.1007/BF01249629. View

Keogan M, Lowe V, Baker M, McDermott V, Lyerly H, Coleman R . Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging. Abdom Imaging. 1997; 22(3):332-7. DOI: 10.1007/s002619900202. View

Kim S, Chung J, Kim B, Kim S, Jeong J, Lee D . Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PET. Clin Positron Imaging. 2003; 2(5):273-279. DOI: 10.1016/s1095-0397(99)00030-8. View

10.

Yasuda S, Fujii H, Nakahara T, Nishiumi N, Takahashi W, Ide M . 18F-FDG PET detection of colonic adenomas. J Nucl Med. 2001; 42(7):989-92. View

11.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View

12.

Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z . PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med. 2005; 46(5):758-62. View

13.

Bar-Shalom R, Valdivia A, BLAUFOX M . PET imaging in oncology. Semin Nucl Med. 2000; 30(3):150-85. DOI: 10.1053/snuc.2000.7439. View

14.

Gallagher B, Fowler J, Gutterson N, MacGregor R, Wan C, Wolf A . Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med. 1978; 19(10):1154-61. View

15.

Okuno T, Fu K, Sano Y, Yoshino T, Murakami K, Ochiai A . Early colon cancers detected by FDG-pet: a report of two cases with immunohistochemical investigation. Hepatogastroenterology. 2004; 51(59):1323-5. View